Transition Therapeutics Inc. - 893716209
Sector:
Healthcare
· Industry:
Medicinal Chemicals & Botanical Products
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2014
· Q4 2013
Value (USD)
Total reported value ($000)
$69.99M
QoQ value delta ($000)
+$21.26M
(+43.62%)
Implied price effect (QoQ)
+40.13%
Shares
Total shares
8,780,841
QoQ shares delta
+213,455
(+2.49%)
Total shares held by funds (by quarter)
Top holders (Q1 2014)
Top 25 only
Full list
Early Q2 2014 data: only 8 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 34,170 | 4,287,412 | 3.9% |
| FMR LLC | 32,009 | 4,016,132 | 0.0% |
| HOLLENCREST SECURITIES LLC | 1,143 | 143,002 | 0.17% |
| RENAISSANCE TECHNOLOGIES LLC | 1,045 | 131,100 | 0.0% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 383 | 48,045 | 0.01% |
| VESTOR CAPITAL, LLC | 340 | 42,600 | 0.12% |
| FineMark National Bank & Trust | 182 | 22,807 | 0.03% |
| BlackRock Institutional Trust Company, N.A. | 172 | 21,597 | 0.0% |
| HighTower Advisors, LLC | 140 | 17,500 | 0.0% |
| PNC FINANCIAL SERVICES GROUP, INC. | 131 | 16,400 | 0.0% |
| CIBC World Markets Inc. | 128 | 16,073 | 0.0% |
| Plante Moran Financial Advisors, LLC | 68 | 8,534 | 0.07% |
| MORGAN STANLEY | 49 | 6,238 | 0.0% |
| DEUTSCHE BANK AG\ | 7 | 901 | 0.0% |
| Tower Research Capital LLC | 7 | 860 | 0.0% |
| FIRST MANHATTAN CO | 5 | 666 | 0.0% |
| ROYAL BANK OF CANADA | 5 | 622 | 0.0% |
| WELLS FARGO & COMPANY/MN | 2 | 225 | 0.0% |
| BANK OF MONTREAL /CAN/ | 1 | 111 | 0.0% |
| TORONTO DOMINION BANK | 0 | 16 | 0.0% |